Dental Composition Doxycycline Triamcinolone Root Canal Staining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current intracanal medicaments for root canal therapy, such as those containing demeclocycline, cause tooth staining due to photo-oxidation and have limitations in antibacterial substantivity and anti-inflammatory effects, while alternatives like clindamycin-based medicaments face issues with bacterial resistance and lack of substantivity.
Innovation Solution
Formulating an endodontic composition with doxycycline hyclate and triamcinolone acetonide, which provides enhanced antibacterial substantivity and anti-inflammatory effects without causing significant tooth staining, and can be used for extended periods in root canal therapy and periodontal disease treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If demeclocycline-based intracanal medicament is used, then antibacterial substantivity is improved, but tooth staining occurs due to photo-oxidation
Solution Approach 1:
The patent changes the chemical parameter of the antibiotic from demeclocycline to doxycycline hyclate, which has different photochemical properties. Doxycycline exhibits significantly reduced tendency to cause tooth staining through photo-oxidation while maintaining the desired antibacterial substantivity and slow release characteristics over extended periods.
Solution Approach 2:
The patent creates a composite medicament formulation combining doxycycline hyclate with triamcinolone acetonide (a corticosteroid) and various excipients. This composite approach allows the antibiotic component to provide substantivity while the anti-inflammatory component addresses inflammation, and the formulation system controls release kinetics to minimize staining potential.
2Object-affected harmful factors
If clindamycin-based medicament is used, then tooth staining is avoided, but bacterial resistance develops and substantivity is reduced
Solution Approach 1:
The patent selects doxycycline hyclate which has different pharmacokinetic parameters compared to clindamycin. Doxycycline demonstrates superior substantivity with slow release over weeks, whereas clindamycin lacks substantivity. Additionally, doxycycline has different antibacterial spectrum characteristics that reduce resistance development while maintaining effectiveness.
3Duration of action of moving object
If intracanal medicament is used for extended period, then antibacterial effect is improved, but inflammation may worsen due to lack of anti-inflammatory action
Solution Approach 1:
The patent merges two distinct therapeutic functions into a single medicament formulation: doxycycline hyclate provides prolonged antibacterial action, while triamcinolone acetonide provides anti-inflammatory action. This combined formulation allows both functions to work synergistically during the extended treatment period without requiring separate applications.
Solution Approach 2:
The intracanal medicament is designed with multi-functionality to simultaneously address bacterial infection and inflammatory response. The formulation serves multiple purposes: antibacterial substantivity, anti-inflammatory action, and slow release kinetics, making it a universal solution for infected root canal systems with associated inflammation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces bacteria and inflammation in the root canal system for an extended period, up to 2-4 weeks, without causing tooth staining, and is effective in treating chronic periodontitis and peri-implantitis.
Implementation Method 1
Demeclocycline is a member of the tetracycline family of bacteriostatic antibiotics which exert actions on protein synthesis by binding to ribosomes
Implementation Method 2
these are able to diffuse over a number of weeks in adult teeth
Implementation Method 3
It has been demonstrated that tetracyclines form a strong reversible bond with hard tissues and that they exhibit slow release over extended periods of time
Implementation Method 4
This is due to the formation of strongly coloured compounds between the dentine of the roots and crown of teeth and the demeclocycline, which then undergo photo-oxidation
Data Source
AI summary
A dental composition comprising a therapeutically effective amount of doxycycline hyclate and a therapeutically effective amount of triamcinolone acetonide and use in dental treatment.